PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2117020
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2117020
Energy-based Aesthetic Devices Market size was valued at US$ 5,908.1 Million in 2025, expanding at a CAGR of 15.8% from 2026 to 2033.
Energy-based aesthetic devices offer laser, intense pulsed light, radiofrequency, ultrasound, and other forms of energy to remove unwanted hair, reduce the signs of aging, remove tattoos, resurface the skin, tighten the skin, perform body contouring, and treat veins. Such devices consist of a source of energy, applicators, cooling systems, control and computer software, and other accessories. They are used in dermatology clinics, plastic surgery, medical spas, and aesthetic surgical clinics. RF microneedling treatments have faced specific regulatory concerns about the significance of proper treatment settings, operator training, and the adequate use of devices in 2025. Therefore, the development of products that allow for controlled delivery of energy to the skin, individualization of treatments, and the ability to treat multiple conditions with one device while also ensuring the necessary safety parameters is in demand.
Energy-based Aesthetic Devices Market- Market Dynamics
Clinical Validation Is Strengthening Purchasing Decisions
Clinical evidence for aesthetic-device selection is becoming important, as clinics are prioritizing predictable outcomes alongside technological versatility. As such, systems that allow for accurate and adjustable levels of energy delivered to the targeted site, consistent application, built-in cooling mechanisms, and proven effectiveness across a range of treatments are preferred, as they enable addressing diverse indications with fewer devices, thus optimizing the bottom line. The 2025 ASDS Consumer Survey, which included over 3,500 US respondents, identified that 70% were considering a cosmetic procedure, while 94% used rating and review websites when narrowing the search field, which highlights the importance of offering credible treatment outcomes and evidence as the preference driver alongside expert advice. As such, companies are urged to integrate clinical evidence, combined with technological innovation and relevant training and support offerings.
The Global Energy-based Aesthetic Devices Market is segmented on the basis of Product Type, Application, End User, Technology, and Region.
Laser technology currently holds a significant position in the market due to its ability to deliver energy at a specific wavelength for targeting hair follicles, pigmentation, blood vessels, and damaged skin. Due to their proven technologies, high levels of clinical research, and versatility, these devices are widely adopted in the medical and aesthetics fields. In 2025, the latest developments of Lumenis' SPLENDOR X platform incorporated the ability to deliver two wavelengths and additional digital functions, representing the continuous improvement of the established technology. Similarly, IPL devices are relevant for achieving photo rejuvenation and treating hyperpigmentation, whereas radiofrequency and ultrasound devices compete for the lead in tissue-tightening and body-contouring treatments. Therefore, the product type is primarily determined by the intended applications and their level of specialization, degree of clinical validation, energy density, and versatility.
The application spectrum of energy-based aesthetic devices determines the general direction of treatment, which can include hair removal, skin rejuvenation, tissue tightening, body contouring, and vascular treatments. Within the hair removal segment, treatments involve scheduled cycles, leaving the choice of method and energy parameters to the providers. In contrast, the results of body contouring and tissue tightening treatments largely depend on the patient's characteristics and require careful pre- and post-treatment care. According to ISAPS, the number of hair removal procedures performed by plastic surgeons worldwide accounts for 1,487,130 cases, and the number of non-surgical skin tightening procedures reaches 1,239,306 cases in 2024 compared to 2025. The annual level of procedures indicates their frequency and reflects the overall popularity of specific treatments. Therefore, companies offer devices that allow addressing multiple indications to increase the utilization rate of a single platform.
Energy-based Aesthetic Devices Market- Geographical Insights
North America is supported by an established dermatology care infrastructure, expert professionals, and well-developed medical device oversight, all contributing to the region's high potential for the adoption of innovative energy-based aesthetic technologies at both institutional and personal levels. Moreover, purchasing decisions in the U.S. are strongly driven by clinical evidence, professional reputation, and patient feedback, as well as the treatment's versatility and regulatory status. As such, the 2025 ASDS Consumer Survey revealed that 70% of respondents were planning to undergo some type of cosmetic procedure during the year, whereas eight out of the 15 surveyed treatments had an overall satisfaction score of "very satisfied" or "somewhat satisfied" from over 95% of patients. Therefore, it can be asserted that the demand for these treatments is primarily driven by outcome data and professional credibility. In turn, the U.S. market should remain a major driver for physician-modified adoption of technically advanced aesthetic treatment platforms.
The European market presents a significant opportunity for energy-based aesthetic technologies due to the developed clinical infrastructure and the region's regulatory environment. During 2025, a number of relevant regulatory updates were introduced, which impacted the way medical devices are documented, evaluated, and monitored. Notably, in December 2025, the European Commission published proposed regulations to simplify the Union's medical device regulations. The new guidance includes a list of procedures applicable to medical devices, which allows essential aspects, such as risk management, to be considered more efficiently while ensuring patient safety. Thus, it can be stated that the European market environment promotes the adoption of innovative yet safe technologies by physicians and patients. At the same time, it requires manufacturers to provide substantial clinical and technical evidence for every treatment indication covered, as well as ensuring traceability throughout the distribution chain and post-market clinical follow-up.
Competition is increasingly focused on the combination of energy, software, cooling, safety, evidence, and partner ecosystems around treatments, and not only on the equipment itself. For example, according to Lumenis, it has sold more than 30,000 M22 devices in more than 100 countries by 2025, while also bringing new platforms that offer digital treatments and a wide range of applications. However, other companies focus on different wavelengths, variations in radiofrequency and ultrasound, applicators, clinical alliances, approvals, and the education of clinicians. Moreover, in addition to the volume of sales, the provision of services and the accumulation of evidence over the life cycle of devices are essential factors in retaining competitiveness and ensuring continued use. Thus, the competition is intense and multifaceted, combining platform-level technologies and clinical approaches.
In March 2025, Lumenis announced its entry into the Canadian market after receiving approval from Health Canada. The company's fractional laser hair-loss device was introduced to the country, signifying its re-entry into the realm of regulated markets after its previous launch in the United States.
In April 2025, Lumenis announced an enhancement to the clinical data of its SPLENDOR X, which was launched in certain international markets. The new version of the system featured a dual-wavelength laser for simultaneous treatment, as well as pre-set treatment settings, an improved user interface, and digital tools for specific regions.